These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 23616082

  • 1. Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice.
    Hudachek SF, Gustafson DL.
    J Pharmacokinet Pharmacodyn; 2013 Aug; 40(4):437-49. PubMed ID: 23616082
    [Abstract] [Full Text] [Related]

  • 2. Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel.
    van Waterschoot RA, Lagas JS, Wagenaar E, Rosing H, Beijnen JH, Schinkel AH.
    Int J Cancer; 2010 Dec 15; 127(12):2959-64. PubMed ID: 21351274
    [Abstract] [Full Text] [Related]

  • 3. Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo.
    Lin F, Hoogendijk L, Buil L, Beijnen JH, van Tellingen O.
    Eur J Cancer; 2013 May 15; 49(8):2059-64. PubMed ID: 23422148
    [Abstract] [Full Text] [Related]

  • 4. A physiologically based pharmacokinetic model of docetaxel disposition: from mouse to man.
    Bradshaw-Pierce EL, Eckhardt SG, Gustafson DL.
    Clin Cancer Res; 2007 May 01; 13(9):2768-76. PubMed ID: 17473210
    [Abstract] [Full Text] [Related]

  • 5. Coadministration of lapatinib increases exposure to docetaxel but not doxorubicin in the small intestine of mice.
    Hudachek SF, Gustafson DL.
    Anticancer Drugs; 2013 Oct 01; 24(9):958-68. PubMed ID: 23928571
    [Abstract] [Full Text] [Related]

  • 6. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance.
    Lee HH, Leake BF, Teft W, Tirona RG, Kim RB, Ho RH.
    Mol Cancer Ther; 2015 Apr 01; 14(4):994-1003. PubMed ID: 25695959
    [Abstract] [Full Text] [Related]

  • 7. Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients.
    Fajac A, Gligorov J, Rezai K, Lévy P, Lévy E, Selle F, Beerblock K, Avenin D, Saintigny P, Hugonin S, Bernaudin JF, Lokiec F.
    Br J Cancer; 2010 Aug 10; 103(4):560-6. PubMed ID: 20628376
    [Abstract] [Full Text] [Related]

  • 8. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel.
    Bosch TM, Huitema AD, Doodeman VD, Jansen R, Witteveen E, Smit WM, Jansen RL, van Herpen CM, Soesan M, Beijnen JH, Schellens JH.
    Clin Cancer Res; 2006 Oct 01; 12(19):5786-93. PubMed ID: 17020985
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic modeling of doxorubicin pharmacokinetics in dogs deficient in ABCB1 drug transporters.
    Gustafson DL, Thamm DH.
    J Vet Intern Med; 2010 Oct 01; 24(3):579-86. PubMed ID: 20337920
    [Abstract] [Full Text] [Related]

  • 10. Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.
    Bardelmeijer HA, Ouwehand M, Buckle T, Huisman MT, Schellens JH, Beijnen JH, van Tellingen O.
    Cancer Res; 2002 Nov 01; 62(21):6158-64. PubMed ID: 12414642
    [Abstract] [Full Text] [Related]

  • 11. Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue-specific drug binding, transport, and metabolism.
    Witta S, Collins KP, Ramirez DA, Mannheimer JD, Wittenburg LA, Gustafson DL.
    Pharmacol Res Perspect; 2023 Feb 01; 11(1):e01052. PubMed ID: 36631976
    [Abstract] [Full Text] [Related]

  • 12. A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors.
    Kelly RJ, Robey RW, Chen CC, Draper D, Luchenko V, Barnett D, Oldham RK, Caluag Z, Frye AR, Steinberg SM, Fojo T, Bates SE.
    Oncologist; 2012 Feb 01; 17(4):512. PubMed ID: 22416063
    [Abstract] [Full Text] [Related]

  • 13. Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel.
    Iusuf D, Hendrikx JJ, van Esch A, van de Steeg E, Wagenaar E, Rosing H, Beijnen JH, Schinkel AH.
    Int J Cancer; 2015 Jan 01; 136(1):225-33. PubMed ID: 24825069
    [Abstract] [Full Text] [Related]

  • 14. P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) affect brain accumulation and intestinal disposition of encorafenib in mice.
    Wang J, Gan C, Sparidans RW, Wagenaar E, van Hoppe S, Beijnen JH, Schinkel AH.
    Pharmacol Res; 2018 Mar 01; 129():414-423. PubMed ID: 29155017
    [Abstract] [Full Text] [Related]

  • 15. Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.
    Bruyère A, Declèves X, Bouzom F, Ball K, Marques C, Treton X, Pocard M, Valleur P, Bouhnik Y, Panis Y, Scherrmann JM, Mouly S.
    Mol Pharm; 2010 Oct 04; 7(5):1596-607. PubMed ID: 20604570
    [Abstract] [Full Text] [Related]

  • 16. Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid.
    Shen J, Carcaboso AM, Hubbard KE, Tagen M, Wynn HG, Panetta JC, Waters CM, Elmeliegy MA, Stewart CF.
    Cancer Res; 2009 Jul 15; 69(14):5885-92. PubMed ID: 19567673
    [Abstract] [Full Text] [Related]

  • 17. Optimizing pharmacokinetic bridging studies in paediatric oncology using physiologically-based pharmacokinetic modelling: application to docetaxel.
    Thai HT, Mazuir F, Cartot-Cotton S, Veyrat-Follet C.
    Br J Clin Pharmacol; 2015 Sep 15; 80(3):534-47. PubMed ID: 26095234
    [Abstract] [Full Text] [Related]

  • 18. Customized in silico population mimics actual population in docetaxel population pharmacokinetic analysis.
    Hudachek SF, Gustafson DL.
    J Pharm Sci; 2011 Mar 15; 100(3):1156-66. PubMed ID: 20803616
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Physiologically based pharmacokinetic model of docetaxel and interspecies scaling: comparison of simple injection with folate receptor-targeting amphiphilic copolymer-modified liposomes.
    Lu XF, Bi K, Chen X.
    Xenobiotica; 2016 Dec 15; 46(12):1093-1104. PubMed ID: 26986924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.